| BMI | Body mass index |
| CAT | Catalase |
| CK | Creatine kinase |
| CON | Control |
| CRP | C-reactive protein |
| DHA | Docosahexaenoic acid |
| DOMS | Delayed onset muscle soreness |
| DPA | Docosapentaenoic acid |
| ECC | Eccentric |
| EIMD | Exercise-induced muscle damage |
| EPA | Eicosapentaenoic acid |
| GPx | Glutathione peroxidase |
| IL-1ra | Interleukin-1 receptor antagonist |
| IL-1β | Interleukin-1β |
| IL-2 | Interleukin-2 |
| IL-4 | Interleukin-4 |
| IL-6 | Interleukin-6 |
| IL-8 | Interleukin-8 |
| INT | Intervention |
| LC n-3 PUFA | Long-chain omega-3 polyunsaturated fatty acid |
| LDH | Lactate dehydrogenase |
| Mb | Myoglobin |
| MDA | Malondialdehyde |
| MDS | Muscle damage stimulus |
| MVC | Maximal voluntary contraction |
| NSAIDs | Non-steroidal anti-inflammatory drugs |
| O3I | Omega-3 index |
| PLA | Placebo |
| RBC | Red blood cell |
| RCT | Randomized controlled trial |
| ROM | Range of motion |
| SOD | Superoxide dismutase |
| T-AOC | Total antioxidant capacity |
| TBARS | Thiobarbituric acid reactive substances |
| TNF-α | Tumor necrosis factor-α |
| UAC | Upper arm circumference |
| VAS | Visual analog scale |